ISABS: Personalized Medicine Conference with Nobel Prize Laureates Participation to be held in Dubrovnik, Croatia

Food and Healthcare Press Releases Thursday March 16, 2017 08:37
ZAGREB, Croatia and WASHINGTON--16 Mar--PRNewswire/InfoQuest

International Society for Applied Biological Sciences (ISABS), Mayo Clinic and St. Catherine Hospital in partnership with Philips are organizing "The Tenth ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine" ( http://www.isabs.hr ), to be held in Dubrovnik, June 19th - June 24th, 2017. ISABS Conference is considered to be one of the most important scientific events in biomedicine in 2017. The conference topics includes: personalized and regenerative medicine, pharmacogenetics, molecular diagnostics, stem cell therapy, epigenetics, microbiome, cancer genetics, forensic and anthropological genetics, etc. There is no doubt: the future of medicine will rely on personalized treatments. During the ISABS 2017 Conference we would like to envision the power and advances of personalized medicine that will create significant value for the healthcare system.

(Logo: http://mma.prnewswire.com/media/465687/St_Catherine_Hospital_Logo.jpg )

More than 50 invited speakers from the World's best scientific institutions as well as 500 participants will attend the Conference. Five Nobel Lectures will be given by the Nobel Laureates: prof. Ada Yonath (Weizmann Institute of Science), prof. Robert Huber (Max Planck Institute of Biochemistry), prof. Avram Hershko (Technion), prof. Herald zur Hausen (University of Heidelberg) and prof. Paul Modrich (Duke University).

International Society for Applied Biological Sciences (ISABS) is a member of the Association Academy of the American Academy of Forensic Sciences and one of the most important and influential society in the field of forensic genetics and personalized medicine. ISABS Scientific Committee comprise four Nobel Prize laureates and many of the world's top physicians and scientists.

According to U.S. News & Word Report, Mayo Clinic is the #1 hospital overall, as well as #1 in more specialties than any other hospital in the United States.
St. Catherine Hospital is a European center of excellence, a finalist of the European Business Award and a member of the prestigious group "The Leading Hospitals of The World".

Royal Philips, a leading global company in health technology, is focused on improving people's health and enabling better outcomes with meaningful innovations. Philips is shaping the future of personalized medicine with tools and services that enable patient-specific care with first-time-right decision-making and targeted therapy.

More information on "The Tenth ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine" are available at http://www.isabs.hr .
ISABS 2017 Organizing Committee
info@isabs.hr
Contact: Severina Subotic +385-91-2445-589
Source: International Society for Applied Biological Sciences (ISABS)

Latest Press Release

Covaris Introduces the 96 oneTUBE-10 AFA Plate for Improved NGS Workflows

Today, Covaris Inc. announced the release of the 96 oneTUBE-10 AFA Plate, which enables scalable and simplified workflows by leveraging Covaris' gold standard focused-acoustic technology to meet rapidly increasing Next-Generation Sequencing (NGS) demands...

2018 Empire State Building Run-Up Lottery Registration Opens on November 14, 2017

Runners must enter by December 10 for a chance to participate in the 41st Annual Run-Up on Wednesday, February 7, 2018, at 8:00 p.m. Empire State Realty Trust, Inc. (NYSE: ESRT) today announced that lottery registration for the 2018 Empire State...

Alpinion Medical Systems Launches E-CUBE 8, the New Ultrasound Diagnostic System

One of South Korea's global medical device manufacturers, Alpinion Medical Systems introduced its new E-CUBE 8, the latest and last addition to the E-CUBE lineup. The E-CUBE 8 is a smart, reliable product that ensures high performance with outstanding...

Photo Release: The Royal Danish Embassy and Novo Nordisk Pharma (Thailand) Co., Ltd launch the Blueprint for Change address Diabetes challenge , aligned with national NCD targets

On the 5th November 2017, right after the WDD event at the Vachirabenjatas Park (Suan Rot Fai Park) . Mr.Uffe Wolffhechel, the ambassador of the Royal Danish Embassy, Thailand (right) together with Mr.Mihai Irimescu, General Manager of Novo Nordisk...

Stryker announces publication of the DAWN(TM) Trial results in the New England Journal of Medicine

The New England Journal of Medicine published the results of the DAWN Trial, the first to provide compelling evidence in treating late window and wake-up stroke patients with mechanical thrombectomy. Currently, less than one in 10 patients suffering from...

Related Topics